New hope for kids with brain clots: pill vs. standard care
NCT ID NCT07523347
First seen Apr 20, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study compared a blood-thinning pill (rivaroxaban) to standard blood thinners in 75 children aged 2 months to 18 years with cerebral venous sinus thrombosis (a blood clot in the brain's veins). The goal was to see which treatment was safer and better at clearing the clot. The study measured success by whether the veins returned to normal and tracked any bleeding problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBROSINOVENOUS THROMBOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital
Lahore, Punjab Province, 54600, Pakistan
Conditions
Explore the condition pages connected to this study.